Delivery Order SPE2DB25D3003-SPE2DB25FPWVV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,405.78 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injectors on June 18, 2025, with a completion date of June 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors valued at $2,934.71. This is a firm fixed-price delivery order with an ultimate completion date of July 18, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pen injectors valued at $4,081.35 under a firm fixed-price contract. The order was placed on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $7,473.52 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors on September 12, 2025, with completion targeted for September 15, 2025. This is a firm fixed-price, non-set-aside contract awarded through open competition, with performance to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $2,123.03 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order, issued without a set-aside designation, represents a competitively awarded pharmaceutical supply transaction supporting federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $13,780.15 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors on July 21, 2025, with completion targeted for July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $4,241.13 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors (0.5 ml units). This is a firm fixed-price delivery order with no set-aside designation, completed through open competition. The order is scheduled for ultimate completion on April 25, 2025, with performance based in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a $4,353.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 12, 2025, and performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a single transaction under a larger indefinite delivery vehicle that enables DLA to...
- The Defense Logistics Agency awarded a $10,988.77 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 12, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injections. The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by June 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors with a ceiling value of $1,578.87. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and carries no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPWVVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,439.29 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injectors with a completion date of July 29, 2025. This firm fixed-price delivery order, issued on July 28, 2025, represents a competitively awarded contract with no set-aside designation. The product will be supplied from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in fulfilling diverse pharmaceutical requirements for defense and veteran healthcare systems, with this Mounjaro delivery representing one of numerous individual orders drawn from the overarching IDC framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 7/28/25 |